Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients
Launched by AROOJ KHAN · Dec 17, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of two different iron supplements, Ferrous Sulphate and Iron Polymaltose, to treat iron deficiency anemia in children. Iron deficiency anemia is a condition where children don't have enough iron in their bodies, which can cause fatigue and other health issues. The goal of the study is to find out which of these two iron preparations works better for children in our community. Both medications are commonly used and easily available, but they may have different benefits, side effects, and costs.
To participate in this trial, children must be diagnosed with iron deficiency anemia. However, some children won't be eligible, such as those with certain blood disorders, recent blood transfusions, or specific gastrointestinal issues. If a child joins the study, they will receive one of the iron supplements and the researchers will monitor their health and response to the treatment. This study is important as it could help doctors choose the most effective and safe iron treatment for children with anemia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients having iron deficiency anemia
- Exclusion Criteria:
- • 1. Patients diagnosed as congenital aplastic anemia or thalassemia (Determined from medical record).
- • 2. Patients who were transfused in previous 4 weeks (will be determined on history)
- • 3. Children having mal-absorption syndrome and diarrheal illnesses. (will be determined on history and medical record)
- • 4. Gastrointestinal bleeding suggested by history of hematemesis (bloody vomit), melena (black colored stools) or bloody stools.
About Arooj Khan
Arooj Khan is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on integrity and excellence, Arooj Khan oversees the design, implementation, and management of clinical trials across various therapeutic areas. The organization emphasizes collaboration with healthcare professionals and regulatory bodies to ensure adherence to the highest standards of safety and efficacy. By leveraging cutting-edge technology and data-driven methodologies, Arooj Khan strives to bring groundbreaking treatments to market, ultimately enhancing the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Peshawar, Kpk, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported